Davis Polk advised the representatives of the several underwriters in the offering. Aziyo Biologics, Inc. completed the $50 million initial public offering of common stock. The…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now